4.6 Review

The cure rate of 10-day bismuth-containing quadruple therapy for Helicobacter pylori eradication is equivalent to 14-day: a systematic review and meta-analysis

期刊

CLINICAL AND EXPERIMENTAL MEDICINE
卷 23, 期 4, 页码 1033-1043

出版社

SPRINGER-VERLAG ITALIA SRL
DOI: 10.1007/s10238-022-00953-7

关键词

Helicobacter pylori; Antimicrobial therapy; Bismuth; Duration

向作者/读者索取更多资源

Helicobacter pylori (H. pylori) infection is a major cause of gastrointestinal diseases, and the optimal duration for eradication therapy is still debated. This study compared the clinical effect of 10-day and 14-day bismuth-containing quadruple treatment regimens for H. pylori eradication. Four included studies showed that the 10-day treatment had similar efficacy and lower incidence of adverse effects compared to the 14-day treatment. The 10-day regimen is safe, well-tolerated, and recommended for H. pylori infection.
Helicobacter pylori (H. pylori) infection is a major cause of duodenal ulcers, gastric ulcers, and gastric cancer. However, the optimal duration for H. pylori eradication therapy remains controversial. Most studies have mainly focused on triple therapy, and there is insufficient research on bismuth-containing quadruple therapy. The aim of this study was to compare the clinical effect of the 10-day bismuth-containing quadruple treatment regimen with the 14-day regime in eradicating H. pylori. We searched PubMed, Embase, Web of Science, and the Cochrane Library for randomized controlled trials published in English until May 2022 according to the eligibility criteria. Summary risk ratios (RRs) and 95% confidence intervals (CIs) for eradication rates, adverse effects, and compliance were calculated for included studies. Four studies, involving 1173 patients, were eligible for inclusion. The eradication rate was similar in the 10-day treatment group and the 14-day treatment group in the intention-to-treat analysis (RR 0.97, 95% CI 0.93 to 1.01). Meanwhile, the incidence of adverse effects was lower in patients who received 10 days of treatment than in those who received 14 days of treatment and patients' compliance was almost the same between two groups. Compared to the 14-day bismuth-containing quadruple regimens, 10-day regimens had similar efficacy and lower incidence of adverse effects. Therefore, the 10-day regimen is safe and well-tolerated and should be recommended for H. pylori infection.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据